Review The client has increased intracranial pressure with cerebral edema, and mannitol is administered

Kinh Nghiệm Hướng dẫn The client has increased intracranial pressure with cerebral edema, and mannitol is administered 2022

Hoàng T Thu Thủy đang tìm kiếm từ khóa The client has increased intracranial pressure with cerebral edema, and mannitol is administered được Update vào lúc : 2022-10-13 21:32:05 . Với phương châm chia sẻ Bí quyết Hướng dẫn trong nội dung bài viết một cách Chi Tiết 2022. Nếu sau khi đọc tài liệu vẫn ko hiểu thì hoàn toàn có thể lại phản hồi ở cuối bài để Admin lý giải và hướng dẫn lại nha.

References

Khanna, A, Kahle, KT, Walcott, BP, Gerzanich, V, Simard, JM (2014). Disruption of ion homeostasis in the neurogliovascular unit underlies the pathogenesis of ischemic cerebral edema. Transl Stroke Res 5(1): 3–16.CrossRefGoogle ScholarPubMed

Nội dung chính

What should nurse expect following mannitol administration?Which intervention would the nurse include when planning care for a client who has increased intracranial pressure Iicp )?Which of the following types of drugs might be given to control increased intracranial pressure ICP )?How does mannitol decrease ICP?

Marmarou, A (2007). A review of progress in understanding the pathophysiology and treatment of brain edema. Neurosurg Focus 22(5):E1.Google ScholarPubMed

Simard, JM, Kent, TA, Chen, M, Tarasov, KV, Gerzanich, V (2007). Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol 6(3):258–268.CrossRefGoogle ScholarPubMed

Nilius, B, Droogmans, G (2001). Ion channels and their functional role in vascular endothelium. Physiol Rev 81: 1415–1459.CrossRefGoogle ScholarPubMed

Strange, K (1992). Regulation of solute and water balance and cell volume in the central nervous system J Am Soc Nephrol 3: 12–27.Google ScholarPubMed

Betz, AL, Iannotti, F, Hoff, JT (1989). Brain edema: a classification based on blood-brain barrier integrity. Cerebrovasc Brain Metab Rev 1: 133–154.Google ScholarPubMed

Arch, AE, Seth, KN (2014). Malignant cerebral edema after large anterior circulation infarction: a review. Curr Treat Options Cadiovasc Med 16(1): 275.CrossRefGoogle ScholarPubMed

Mayer, SA, Coplin, WM, Raps, EC (1999). Cerebral edema, intracranial pressure, and herniation syndromes. J Stroke Cerebrovasc Dis 8: 183–191.CrossRefGoogle ScholarPubMed

Lescot, T, Abdennour, L, Boch, AL, Puybasset, L (2008). Treatment of intracranial hypertension. Curr Opin Crit Care 14: 129–134.CrossRefGoogle ScholarPubMed

Rosner, MJ, Coley, IB (1986). Cerebral perfusion pressure, intracranial pressure, and head elevation. J Neurosurg 65: 636–641.CrossRefGoogle ScholarPubMed

Koh, MG, Phan, TG, Atkinson, JL, Wijdicks, EF (2000). Neuroimaging in deteriorating patients with cerebellar infacts and mass effect. Stroke 31: 2062–2067.CrossRefGoogle Scholar

Ryoo, JV, Na, DG, Kim, SS, et al. (2004). Malignant middle cerebral artery infarction in hyperacute ischemic stroke: evaluation with multiphasic perfusion computed tomography maps. J Comput Assist Tomogr 28: 55–62.CrossRefGoogle ScholarPubMed

Yoo, AJ, Sheth, KN, Kimberly, WT, et al. (2013). Validating imaging biomarkers of cerebral edema in patients with severe ischemic stroke. J Stroke Cerebrovasc Dis 22: 742–749.CrossRefGoogle Scholar

Bardutzsky, J, Schwab, S (2007). Antiedema therapy in ischemic stroke. Stroke 38: 3084–3094.CrossRefGoogle Scholar

Chestnut, RM, Temkin, N, Carney, N, et al. (2012). A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med 367(26): 2471–2481.CrossRefGoogle Scholar

Muizelaar, JP, Marmarou, A, Ward, JD, et al. (1991). Adverse effects of prolonged hyperventilation in patients with severe head injury: A randomized clinical trial. J Neurosurg 75: 731–739.CrossRefGoogle ScholarPubMed

Diringer, MN, Scalfani, MT, Zazulia, AR, Videen, TO, Dhar, R (2011). Cerebral hemodynamic and metabolic effects of equi-osmolar doses mannitol and 23.4% saline in patients with edema following large ischemic stroke. Neurocrit Care 14(1): 11– 17.CrossRefGoogle ScholarPubMed

Bhardwaj, A, Ulatowski, JA (2004). Hypertonic saline solutions in brain injury. Curr Opin Crit Care 10: 126–31.Google Scholar

Bhardwaj, A, Ulatowski, JA (1999). Cerebral edema: hypertonic saline solutions. Curr Treat Opt Neurol 1: 179–187.CrossRefGoogle ScholarPubMed

Cremer, OL, Moons, KG, Bouman, EA, et al. (2001). Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet 357: 117–118.CrossRefGoogle ScholarPubMed

Hypothermia after Cardiac Arrest Study Group (2002). Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346: 549–556.CrossRef

Florczak-Rzepka, M, Grond-Ginsbach, C, Montaner, J, Steiner, T (2012). Matrix metalloproteinases in human spontaneous intracerebral hemorrhage: an update. Cerebrovasc Dis 34(4): 249–262.CrossRefGoogle ScholarPubMed

Vahedi, K, Hofmeijer, J, Juettler, E, et al. (2007). DECIMAL, DESTINY, and HAMLET investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomized controlled trials. Lancet Neurol 6(3): 215–222.CrossRefGoogle Scholar

Li, N, Liu, YF, Ma, L, et al. (2013). Association of molecular markers with perihematomal edema and clinical outcome in intracerebral hemorrhage. Stroke 44(3): 658–663.CrossRefGoogle ScholarPubMed

Walcott, BP, Kahle, KT, Simard, JM (2012). Novel treatment targets for cerebral edema. Neurotherapeutics 9(1): 65– 72.CrossRefGoogle ScholarPubMed

Simard, JM, Geng, Z, Silver, FL, et al. (2012). Does inhibiting Sur1 complement rt-PA in cerebral ischemia? Ann N Y Acad Sci 1268: 95–107.CrossRefGoogle ScholarPubMed

Kunte, H, Schmidt, S, Eliasziw, M, et al. (2007). Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke. Stroke 38(9): 2526–2530.CrossRefGoogle ScholarPubMed

Kunte, H, Busch, MA, Trostdorf, K, et al. (2012). Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas. Ann Neurol 72(5): 799–806.CrossRefGoogle ScholarPubMed

Badaut, J, Lasbennes, F, Magistretti, PJ, Regli, L (2002). Aquaporins in brain distribution, physiology, and pathophysiology. J Cereb Blood Flow Metab 22(4): 367–378.CrossRefGoogle ScholarPubMed

Chu, H, Tang, Y, Dong, Q. (2013). Protection of vascular endothelial growth factor to brain edema following intracerebral hemorrhage and its involved mechanisms: effect of Aquaporin-4. PLoS One 8(6):e66051.CrossRefGoogle ScholarPubMed

What should nurse expect following mannitol administration?

One of the most significant adverse effects of mannitol administration is heart failure caused by rapid shifts of fluid into the intravascular space. This is why it is typically contraindicated in patients with heart failure. Another significant adverse effect is worsening cerebral edema.

Which intervention would the nurse include when planning care for a client who has increased intracranial pressure Iicp )?

If a patient is suspected of having increased ICP, immediate interventions should include securing the airway, maintaining adequate oxygenation and ventilation, and providing circulatory support as needed.

Which of the following types of drugs might be given to control increased intracranial pressure ICP )?

Which of the following types of drugs might be given to control increased intracranial pressure (ICP)? Question 19 Explanation: Barbiturates may be used to induce a coma in a patient with increased ICP.

How does mannitol decrease ICP?

Mannitol exerts its ICP-lowering effects via two mechanisms—an immediate effect because of plasma expansion and a slightly delayed effect related to its osmotic action. The early plasma expansion reduces blood viscosity and this in turn improves regional cerebral microvascular flow and oxygenation. Tải thêm tài liệu liên quan đến nội dung bài viết The client has increased intracranial pressure with cerebral edema, and mannitol is administered Intracranial pressure